Turner B C, Hejlesen O K, Kerr D, Cavan D A
Bournemouth Diabetes & Endocrine Centre, Royal Bournemouth Hospital, Dorset, United Kingdom.
Diabetes Technol Ther. 2001 Spring;3(1):99-109. doi: 10.1089/152091501750220064.
The Diabetes Advisory System (DIAS) is a decision-support program developed to assist insulin dose adjustment in type 1 diabetes. In this paper, we show how it might be used to identify impaired absorption or omission of insulin in patients with poorly controlled blood glucose. An evaluation of glucose results from four outpatients with persistent hyperglycemia is presented (age 19-48 years with type 1 diabetes for 13-18 years of duration, HbA1c 9.4-13.6%). Each had completed a 4-day record of blood glucose (BG, pre-meal and bedtime), dietary (carbohydrate) intake, and insulin doses (with injection sites). From these data, DIAS modeled a glucose profile (simulated glucose, SG) for the same period. Qualitative assessments were made of differences between BG and SG, and selective reduction or complete removal of insulin doses where BG >> SG. Large improvements in modeling were attributed to either impaired absorption or omission of insulin. Confirmation of these problems was sought from the patients by detailed consultation and physical examination. Impaired insulin absorption was suspected in two patients, both having significant injection site abnormalities. Insulin omission was suspected in the other two subjects. Both had normal injection sites, and one admitted to missing doses. Following retraining, data from three patients showed noticeable improvements in overall modeling as well as glucose control. Using DIAS in the evaluation of patients with type 1 diabetes may highlight previously unrecognized injection site abnormalities or insulin dose omission. This could assist rational optimization of insulin therapy in cases of persistently poor glucose control.
糖尿病咨询系统(DIAS)是一个旨在辅助1型糖尿病患者进行胰岛素剂量调整的决策支持程序。在本文中,我们展示了该系统如何用于识别血糖控制不佳患者胰岛素吸收受损或遗漏的情况。文中呈现了对4名持续性高血糖门诊患者的血糖结果评估(年龄19 - 48岁,患1型糖尿病13 - 18年,糖化血红蛋白9.4 - 13.6%)。每位患者都完成了一份为期4天的血糖(餐前和睡前)、饮食(碳水化合物)摄入量以及胰岛素剂量(包括注射部位)记录。根据这些数据,DIAS为同一时期模拟了血糖曲线(模拟血糖,SG)。对血糖(BG)和模拟血糖之间的差异进行了定性评估,并在血糖远高于模拟血糖时选择性减少或完全停用胰岛素剂量。建模方面的大幅改善归因于胰岛素吸收受损或遗漏。通过详细咨询和体格检查向患者求证这些问题。两名患者被怀疑存在胰岛素吸收受损,他们都有明显的注射部位异常。另外两名受试者被怀疑存在胰岛素遗漏。他们的注射部位正常,其中一人承认有漏服剂量的情况。经过再培训后,三名患者的数据显示总体建模以及血糖控制都有明显改善。在1型糖尿病患者评估中使用DIAS可能会发现之前未被识别的注射部位异常或胰岛素剂量遗漏情况。这有助于在血糖持续控制不佳的情况下合理优化胰岛素治疗。